Liminal BioSciences Inc. (LMNL) Earning

NASDAQ Currency in USD Disclaimer

$8.50

north_east NA Past Year
Day's range
$8.48
Day's range
$8.5

Liminal BioSciences Inc. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
08/16/2023 Q2 2023 -$2.94 $112,000
03/31/2023 Q1 2023 -$2.46 $136,000
03/15/2023 Q4 2022 -$1.54 $241,000
09/30/2022 Q3 2022 $7.00 $3,000
06/30/2022 Q2 2022 -$1.01 $157,000
03/30/2022 Q1 2022 -$3.41 $0
03/17/2022 Q4 2021 -$5.51 $238,000
09/29/2021 Q3 2021 $24.90 $170,000
07/26/2021 Q2 2021 -$10.70 $25,000
03/30/2021 Q1 2021 -$6.77 $210,000
03/24/2021 Q4 2020 $5.70 -$14.52 -20.22 $1.04 M
09/29/2020 Q3 2020 -$9.79 $639,000
06/29/2020 Q2 2020 -$11.88 $540,000
03/27/2020 Q1 2020 -$11.69 $1.10 M
03/20/2020 Q4 2019 -$6.14 $-17,372,000
09/29/2019 Q3 2019 -$12.70 $5.29 M
06/29/2019 Q2 2019 -$81.22 $8.75 M
03/30/2019 Q1 2019 -$332.58 $8.23 M
12/30/2018 Q4 2018 -$1,238.90 $10.60 M
09/29/2018 Q3 2018 -$343.04 $12.33 M
 

Liminal BioSciences Inc. Earnings: FAQ's

When is Liminal BioSciences Inc.'s earnings date?

Liminal BioSciences Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 7th, 2023 based off last year's report dates.

Did Liminal BioSciences Inc. beat their earnings estimates last quarter?

In the previous quarter, Liminal BioSciences Inc. (:LMNL) reported $2.3 earnings per share (EPS) to beat the analysts' consensus estimate of $1.7 by $0.6.

How can I listen to Liminal BioSciences Inc.'s earnings conference call?

The conference call for Liminal BioSciences Inc.'s latest earnings report can be listened to online.

How can I read Liminal BioSciences Inc.'s conference call transcript?

The conference call transcript for Liminal BioSciences Inc.'s latest earnings report can be read online.

How much revenue does Liminal BioSciences Inc. generate each year?

Liminal BioSciences Inc. (:LMNL) has a recorded annual revenue of $401,000.

How much profit does Liminal BioSciences Inc. generate each year?

Liminal BioSciences Inc. (:LMNL) has a recorded net income of $401,000. Liminal BioSciences Inc. has generated $-9.32 earnings per share over the last four quarters.

What is Liminal BioSciences Inc.'s price-to-earnings ratio?

Liminal BioSciences Inc. (:LMNL) has a price-to-earnings ratio of -1.31 and price/earnings-to-growth ratio is 0.01.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED